SCHEMBL6710193

SCHEMBL6710193

CSCCOc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)n(C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
GRM4 Q14833 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
ROCK1 Q13464 1/20 0.33
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
NR4A2 P43354 1/20 0.32
CHRM3 P20309 1/20 0.32
POLB P06746 1/20 0.31
G6PD P11413 1/20 0.31
GRM5 P41594 1/20 0.31
TP53 P04637 1/20 0.31
MRGPRX1 Q96LB2 1/20 0.31
LCK P06239 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
BCL2L1 Q07817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707977 0.91 IRAK4 (0.37) GRM4LMNAMAPTRXFP1ROCK1
SCHEMBL6710109 0.91 NPSR1 (0.35) LMNAMAPTRXFP1POLBGRM5
SCHEMBL6711705 0.90 MAPT (0.36) GRM4LMNAMAPTRXFP1ROCK1
SCHEMBL6707789 0.89 LMNA (0.33) LMNAMAPTRXFP1SMN1; SMN2
SCHEMBL6709977 0.89 GRM4 (0.36) PPARGGRM4LMNAMAPTRXFP1
SCHEMBL6710050 0.87 TSHR (0.38) GRM4LMNAMAPTRXFP1POLB
SCHEMBL6707711 0.87 MAPT (0.39) GRM4LMNAMAPTPOLBG6PD
SCHEMBL6710394 0.86 KDM1A (0.37) GRM4LMNAMAPTCHRM3MRGPRX1
SCHEMBL6710113 0.85 IRAK4 (0.39) PPARGGRM4LMNAMAPTRXFP1
SCHEMBL6710121 0.85 IRAK4 (0.39) PPARGGRM4LMNAMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PPARG 262/4885PPARA 138/4885GRM4 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.